(16 days)
Not Found
No
The description focuses on the mechanical design and safety features of a syringe, with no mention of AI or ML.
No.
The syringe is used to inject or withdraw fluids, which are actions related to delivery or removal, not directly treating a disease or condition. While essential for medical procedures, the syringe itself does not provide a therapeutic effect.
No
Explanation: The device, the Inviro Snap Safety Syringe, is used to inject or withdraw fluids from the body and is designed to prevent needle stick injuries. Its noted uses are therapeutic/interventional, not diagnostic.
No
The device description clearly outlines a physical syringe with mechanical components (plunger, adapter, barrel) and mentions sterilization and packaging, indicating it is a hardware device.
Based on the provided information, the Inviro Snap Safety Syringe is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to "inject fluids into, or withdraw fluids from, the body." This describes a direct interaction with the human body for therapeutic or diagnostic purposes within the body, not for testing samples outside the body.
- Device Description: The description focuses on the mechanical function of the syringe for fluid handling and needle stick prevention. There is no mention of collecting or analyzing biological samples for diagnostic information.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Providing diagnostic information about a patient's health status
- Reagents or assays
- Calibration or quality control procedures related to diagnostic testing
The device is clearly intended for administering or withdrawing substances directly from a patient, which falls under the category of a medical device, but not specifically an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Inviro Snap Safety Syringe is used to inject fluids into, or withdraw fluids from, the body. In addition, the Inviro Snap Safety Syringe is designed to aid in the prevention of needle stick injuries.
Product codes
MEG
Device Description
The Inviro Snap Safety Syringe is a retractable type anti-needlestick syringe. The Inviro Snap Safety Syringe is sterilized by gamma irradiation and supplied sterile in blister pack. One hundred blister packs are packaged in a chipboard box. Each Blister pack and chipboard box is labeled with the contents and the appropriate information per the FDA's Quality System Regulation and Labeling requirements.
After use, with the plunger fully compressed, a 180 degree rotation of the plunger couples the Adapter to the end of the plunger. After this coupling occurs withdrawal of the plunger causes the Adapter and the attached needle to be withdrawn into the safety of the barrel. In this position against the flange, lateral pressure on the plunger results in a controlled fracture of the plunger. Both the syringe and plunger are discarded in a Sharps container.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Prior to testing, First Article Inspections were conducted on all components. In addition, material verification was performed on all components.
The Inviro Snap Safety Syringe assembly was tested per the requirements of the ISO-FDA Modified Matrix, FDA/ODE General Program Memorandum - # G95-1 and ANSI/AAMI/ISO 10993-1:1997 for a External communicating device, Blood path, indirect for a period less than 30 days.
Biocompatibility testing included Cytotoxicity, Intracutaneous Reactivity, Maximization Sensitization Study, In Vitro Hemolysis Study, USP and ISO Systemic Toxicity Studies and USP Prorogen Study. The Inviro Snap Safety Syringe met all of the biocompatibility requirements.
Tests were conducted to determine the accuracy of the scale on the Inviro Snap Safety Syringe. These tests consisted of weighing the syringe, filling the syringe to various increments, weighing the syringe, expelling the fluid and weighing the syringe once again. All weights were recorded. The mean and standard deviation was calculated for all increments. The scale met all accuracy requirements.
Verification Testing consisted of component and interface testing and finished assembly testing. The following tests were performed to verify the compatibility between the interfacing safety syringe components:
-
- Force to assemble cap In this test, the average force along with the standard deviation is determined to assemble and disassemble the Cap from the Barrel. A good seal between the cap and barrel will reduce the chance that the cap will fall off and expose the needle.
-
- Force to separate Adapter from Cannula This test was conducted per ISO 7864:1993(E) paragraph 13.1. The average force along with the standard deviation was determined for separating the cannula from the adapter. The ISO Standard requires a minimum of 4,9 lbs of force to separate the cannula from the adaptor.
-
- Force to Snap off Plunger A torque gauge is used to snap off the plunger from the syringe. This test will verify that the plunger is not too difficult to snap off.
-
- Cannula Bending Test To verify the cannula can withstand the forces required to penetrate a medicine bottle septum.
-
- Force required to press out Adapter from Barrel This test determines the force required to push/press out the adaptor from the barrel. This test will assure that the adaptor is not pushed out during an injection.
To verify that the assembled devices met the design requirements, the following tests were performed:
- Freedom from air and liguid leakage past seals Medication leakage can 1. occur around the plunger seal or around the needle holder. This test involves blocking the needle lumen and forcing the plunger handle
- forward. Pressure is increased incrementally and held for several seconds at each increment. The pressure at which leakage occurs and the location of the leak is recorded.
-
- Pressure Leakage Test - This test was conducted per ISO 7886-1:1993(E) Annex D. In this test series, the system was submerged in liquid and an internal pressure of 43.5 and 400 PSI was applied. Any leakage past the seals was recorded.
-
- Plunger Action Force - This test was conducted per ISO 7886-1:1993(E) Annex G. This test measures the force to initiate plunger action as well as the maximum and minimum forces required to move the plunger within the Barrel. :
The intended use of the Inviro Snap Safety Syringe is identical to that of the cited predicate device. Verification testing showed that any differences in technological characteristics were insignificant and do not raise new issues of safety or effectiveness.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5860 Piston syringe.
(a)
Identification. A piston syringe is a device intended for medical purposes that consists of a calibrated hollow barrel and a movable plunger. At one end of the barrel there is a male connector (nozzle) for fitting the female connector (hub) of a hypodermic single lumen needle. The device is used to inject fluids into, or withdraw fluids from, the body.(b)
Classification. Class II (performance standards).
0
SEP 2 4 2003
510(k) Summary (As required by 21 CFR 807.92(a))
-
Submitter Information A.
Inviro Medical 885 West Georgia Street Suite 1200 Vancouver, BC V6C3E8 Canada Phone Number: 604-688-6115 604-451-7002 Fax Number: F. Ross Sharp, MD Contact: President August 25, 2003 Date: -
B. Device Information
Trade/Proprietary Name: | Inviro Snap Safety Syringe |
---|---|
Common name of device: | Piston Syringe with Safety Feature |
Classification Name: | Piston Syringe with Safety Syringe |
Predicate Device: | Inviro 6 cc Syringe |
Predicate 510(k) #: | K941450 |
- D. Device Description:
்
:
The Inviro Snap Safety Syringe is a retractable type anti-needlestick syringe. The Inviro Snap Safety Syringe is sterilized by gamma irradiation and supplied sterile in blister pack. One hundred blister packs are packaged in a chipboard box. Each Blister pack and chipboard box is labeled with the contents and the appropriate information per the FDA's Quality System Regulation and Labeling requirements.
1
After use, with the plunger fully compressed, a 180 degree rotation of the plunger couples the Adapter to the end of the plunger. After this coupling occurs withdrawal of the plunger causes the Adapter and the attached needle to be withdrawn into the safety of the barrel. In this position against the flange, lateral pressure on the plunger results in a controlled fracture of the plunger. Both the syringe and plunger are discarded in a Sharps container.
-
ய Intended Use:
The Inviro Snap Safety Syringe is used to inject fluids into, or withdraw fluids from, the body. In addition, the Inviro Snap Safety Syringe is designed to aid in the prevention of needle stick injuries. -
Comparison of Required Technological Characteristics: に.
Information was submitted to demonstrate that there are no significant differences in technological characteristics between the Inviro Snap Safety Syringe and the cited predicate device. -
Summary and Conclusion of Nonclinical and Clinical Tests: G.
Prior to testing, First Article Inspections were conducted on all components. In addition, material verification was performed on all components.
The Inviro Snap Safety Syringe assembly was tested per the requirements of the ISO-FDA Modified Matrix, FDA/ODE General Program Memorandum - # G95-1 and ANSI/AAMI/ISO 10993-1:1997 for a External communicating device, Blood path, indirect for a period less than 30 days.
Biocompatibility testing included Cytotoxicity, Intracutaneous Reactivity, Maximization Sensitization Study, In Vitro Hemolysis Study, USP and ISO Systemic Toxicity Studies and USP Prorogen Study. The Inviro Snap Safety Syringe met all of the biocompatibility requirements.
Tests were conducted to determine the accuracy of the scale on the Inviro Snap Safety Syringe. These tests consisted of weighing the syringe, filling the syringe to various increments, weighing the syringe, expelling the fluid and weighing the syringe once again. All weights were recorded. The mean and standard deviation was calculated for all increments. The scale met all accuracy requirements.
2
Verification Testing consisted of component and interface testing and finished assembly testing. The following tests were performed to verify the compatibility between the interfacing safety syringe components:
-
- Force to assemble cap In this test, the average force along with the standard deviation is determined to assemble and disassemble the Cap from the Barrel. A good seal between the cap and barrel will reduce the chance that the cap will fall off and expose the needle.
-
- Force to separate Adapter from Cannula This test was conducted per ISO 7864:1993(E) paragraph 13.1. The average force along with the standard deviation was determined for separating the cannula from the adapter. The ISO Standard requires a minimum of 4,9 lbs of force to separate the cannula from the adaptor.
-
- Force to Snap off Plunger A torque gauge is used to snap off the plunger from the syringe. This test will verify that the plunger is not too difficult to snap off.
-
- Cannula Bending Test To verify the cannula can withstand the forces required to penetrate a medicine bottle septum.
-
- Force required to press out Adapter from Barrel This test determines the force required to push/press out the adaptor from the barrel. This test will assure that the adaptor is not pushed out during an injection.
To verify that the assembled devices met the design requirements, the following tests were performed:
- Freedom from air and liguid leakage past seals Medication leakage can 1. occur around the plunger seal or around the needle holder. This test involves blocking the needle lumen and forcing the plunger handle
- forward. Pressure is increased incrementally and held for several seconds at each increment. The pressure at which leakage occurs and the location of the leak is recorded.
-
- Pressure Leakage Test - This test was conducted per ISO 7886-1:1993(E) Annex D. In this test series, the system was submerged in liquid and an internal pressure of 43.5 and 400 PSI was applied. Any leakage past the seals was recorded.
-
- Plunger Action Force - This test was conducted per ISO 7886-1:1993(E) Annex G. This test measures the force to initiate plunger action as well as the maximum and minimum forces required to move the plunger within the Barrel. :
The intended use of the Inviro Snap Safety Syringe is identical to that of the cited predicate device. Verification testing showed that any differences in technological characteristics were insignificant and do not raise new issues of safety or effectiveness.
3
Conclusion:
.
The Inviro Snap Safety Syringe is substantially equivalent to the Inviro 6 cc Syringe in indications for use and technological characteristics.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract image of an eagle or bird-like figure, composed of three curved lines.
Public Health Service
SEP 2 4 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Inviro Medical C/O Mr. James Barley Regulatory Affairs JB & Associates 28481 LA Falda Laguna Niguel, California 92677
Re: K032780
Trade/Device Name: Inviro Snap Safety Syringe, 1cc, 3cc, 5cc, and 10cc, Regulation Number: 880.5860 Regulation Name: Piston Syringe with Safety Feature Regulatory Class: II Product Code: MEG Dated: September 3, 2003 Received: September 8, 2003
Dear Mr. Barley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Mr. Barley
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Runre
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use Statement
510(k) Number (if known): _______________
Device Name:
Indications for Use:
The Inviro Snap Safety Syringe is used to inject fluids into, or withdraw fluids from, the body. In addition, the Inviro Snap Safety Syringe is designed to aid in the prevention of needle stick injuries.
Patrice Laurenti
ivision Sign-Off Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K032780
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
行命令和自己的身体的是否是是是是是是是在国家的是非常的是非常的是非常是
Concurrence of CDRH, Office of Device Evaluation (ODE)
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Prescription Use __ (Per 21 CFR 801.109)
OR
Over-The- Counter Use ________________________________________________________________________________________________________________________________________________________